Ophthalmic Devices - Western Asia

  • Western Asia
  • The Ophthalmic Devices market market in Western Asia is expected to achieve a revenue of US$1.80bn by the year 2024.
  • The revenue is projected to grow at an annual growth rate of 5.57% (CAGR 2024-2029), leading to a market volume of US$2.36bn by 2029.
  • In comparison to other countries worldwide, the United States is expected to generate the highest revenue in the Ophthalmic Devices market market, reaching US$14,000.00m in 2024.
  • In Western Asia, the ophthalmic devices market is experiencing a surge in demand due to the region's rising prevalence of eye diseases.

Key regions: Germany, Italy, France, Japan, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Ophthalmic Devices market in Western Asia is experiencing significant growth and development due to various factors such as increasing customer preferences for advanced eye care solutions, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Western Asia are shifting towards advanced ophthalmic devices that offer better accuracy, precision, and comfort. Patients are increasingly seeking innovative solutions for vision correction, such as laser eye surgery and implantable contact lenses. Additionally, there is a growing demand for diagnostic devices that can detect eye diseases at an early stage, leading to a higher adoption of optical coherence tomography (OCT) and fundus cameras. Trends in the market indicate a rise in the number of ophthalmic clinics and hospitals, which are equipped with state-of-the-art technology and specialized services. This trend is driven by the increasing prevalence of eye disorders and the growing awareness about the importance of regular eye check-ups. Moreover, there is a growing emphasis on telemedicine and remote monitoring in the ophthalmic field, enabling patients in remote areas to access quality eye care services. Local special circumstances in Western Asia contribute to the development of the Ophthalmic Devices market. The region has a high prevalence of diabetes, which is a major risk factor for eye diseases such as diabetic retinopathy. This drives the demand for ophthalmic devices that can effectively diagnose and manage diabetic eye conditions. Additionally, the region has a large aging population, leading to a higher incidence of age-related eye diseases such as cataracts and glaucoma. This creates a significant demand for surgical devices and implants. Underlying macroeconomic factors also play a role in the growth of the Ophthalmic Devices market in Western Asia. Economic development and increasing disposable income levels in countries like Saudi Arabia, United Arab Emirates, and Qatar have led to higher healthcare spending, including investments in advanced ophthalmic devices. Furthermore, government initiatives to improve healthcare infrastructure and expand access to eye care services have contributed to the market growth. In conclusion, the Ophthalmic Devices market in Western Asia is witnessing significant growth due to customer preferences for advanced eye care solutions, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for innovative ophthalmic devices is driven by the need for accurate diagnosis, precision in surgical procedures, and the growing awareness about the importance of regular eye check-ups. With the increasing prevalence of eye disorders and the aging population, the market is expected to continue its upward trajectory in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)